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doi:10.1016/j.kjms.2012.02.005Abstract Adrenal myelolipoma is a rare, nonfunctioning, and benign tumor. We report our
experience of surgically treated patients from a single institute and review the literature.
Six patients (three men and three women) were diagnosed and received surgical intervention.
A retrospective analysis was done by reviewing medical records. In our series, three patients
were diagnosed incidentally and the others were discovered due to symptoms. All received
surgery, including laparoscopic adrenalectomy. There was no recurrence. In the literature
review, right adrenal gland was dominant and the prevalent age was from the fourth to sixth
decades. The most common symptoms were abdominal and flank pain. Adrenal myelolipoma is
uncommon and easily confused with malignancy when of large size (6 cm). Surgery may be
reserved for symptomatic cases and those lesions that cannot reliably be diagnosed. Large
tumors (6 cm) can be excised surgically or laparoscopically.
Copyright ª 2012, Elsevier Taiwan LLC. All rights reserved.Introduction
Adrenal myelolipoma is a rare, nonfunctioning, and benign
tumor. It was first described by Gierke in 1905 and named
by Oberling in 1929 [1]. The tumor is composed of mature
fat tissue and hematopoietic tissues. Initially, some cases
were suspected to be malignant diseases such asof Urology, Kaohsiung Chang
Gung University College of
, Kaohsiung, Taiwan.
.com.tw (P.-H. Chiang).
vier Taiwan LLC. All rights reservliposarcoma and leiomyosarcoma in an image study. Case
reports are limited, especially concerning large adrenal
myelolipoma. We report our experience of large adrenal
myelolipoma and review the literature.Patients and methods
Data for the present series were collected from the
Department of Urology, Chang Gung Memorial Hospital,
Kaohsiung Medical Center, between 2001 and 2010. Six
patients (three men and three women) were diagnosed and
received surgical intervention. The initial diagnosis wased.
Table 1 Patient characteristics, clinical data and management.
Age Sex Presentation Image
study
Side Tumor
size (cm)
Management Follow-up
(month)
Initial impression
44 F Incidentally CT, MRI Right 14 Reversed L incision 33 Right renal hamartoma
47 F Incidentally CT Right 6 Retroperitoneoscopy 40 Right adrenal myelolipoma
51 M Incidentally CT Right 9.5 Subcostal incision 51 Suprarenal lipoma or liposarcoma
48 M Left palpable
mass
CT Left 13.5 Midline incision 114 Hamartoma D/D: liposarcoma
45 M Abdominal
pain
CT, MRI Right 16.5 Subcostal incision 25 Myelolipoma, liposarcoma,
leiomyosarcoma, angiomyelolipoma
51 F Abdominal
fullness
and pain
CT Right 7.5 Laparoscopy 4 Right adrenal myelolipoma;
D/D: renal angiomyolipoma
CT Z computerized tomography; F Z female; M Z male; MRI Z magnetic resonance imaging.
378 S.-W. Hsu et al.based on computerized tomography (CT) and magnetic
resonance imaging (MRI), and a definitive diagnosis was
made according to pathological report. A retrospective
analysis was performed by reviewing medical records and
image studies. We also reviewed 125 cases reported in the
literature [1e39], to which we now add six new cases.Figure 1. A. The fat in an adrenal myelolipoma is of high signal
T2-weighted images. C. Computed tomogram scan-a well defined
14.0  10.0  7.0 cm.Results
Patient mean age was 47.7  2.94 years (Table 1). All
patients received image study by CT and two also received
MRI. All tumors in our series were greater than 6 cm.
The largest was 16.5  12.5  4.8 cm3. The CT imageintensity on T1- weighted. B. Intermediate signal intensity on
heterogeneous adrenal mass. D. The encapsulated tumor was
Figure 2. Adipose tissue and bone marrow elements partially surrounded by epithelium of adrenal cortex and a fibrous capsule
with active bone marrow elements and extensive hemorrhaging (H&E stain, 40 and 200).
Adrenal myelolipoma 379usually showed well-circumscribed, heterogeneous minimal
enhancement with a lesion of low density. The MRI similarly
demonstrated a well-defined heterogeneous mass with
areas of fat component. There was high signal intensity on
the T1-weighted images because of plenty of adipose
tissue. Intermediate signal intensity on the T2-weighted
images may be found due to mixed fat and marrow
tissues (Fig. 1). Three patients suffered from clinical
symptoms, while the other three were found incidentally.
Although there were some typical images in CT and MRI,
only one case in our series was diagnosed definitely prior to
operation. Four patients received surgical adrenalectomy,
and the others laparoscopic adrenalectomy. The surface of
the tumor glistened with variegated discoloration. The cut
surface appeared yellowish to dark-brown in color, with
soft consistency. The pathological sections showed adrenal
gland tumor comprising mature fat tissue with active bone
marrow elements and extensive hemorrhaging (Fig. 2). The
analysis showed occurrence to be slightly more often in
males than in females, with a male-to-female ratio ofFigure 3. Most cases were diagnosed between1.34:1. This is similar to autopsy results with a male-to-
female ratio of 1.75:1 [1]. Most cases were diagnosed at
between 40 and 69 years of age (Fig. 3). Adrenal myeloli-
poma is usually unilateral. Eighty-five of 131 (64.9%)
patients had tumors located on the right side, and 30 of 131
(22.9%) patients had on the left side. Only 16 of 131 (12.2%)
cases were bilateral. Most cases were found incidentally.
The most common symptoms in this study were abdominal
and flank pain (Fig. 4). Twelve cases of spontaneous rupture
were reported in the literature [29e39]. All of these were
greater than 6 cm, and the smallest was 7 cm. The spon-
taneous rupture occurred in 12 of 69 (17.4%) cases in the
group of large tumor size (6 cm).Discussion
The incidence of adrenal myelolipoma at autopsy varies
between 0.08% and 0.2% [1]. The etiology of adrenal
myelolipoma is uncertain. Some reports state it to be40 and 69 years of age. Unknown: 18 cases.
Figure 4. The most common symptoms in this study were abdominal and flank pain.
380 S.-W. Hsu et al.associated with hypertension, atherosclerosis, diabetes
mellitus, and other chronic diseases [4].
In most patient cases, adrenal myelolipoma is small and
asymptomatic [5,19]. However, 68 of 131 (51.9%) cases in
this literature review had clinical symptoms. This may be
due to case recruitment. All tumors in our series were
larger than 6 cm. In our series, two of six patients suffered
from abdominal pain prior to operation. Logically, larger
adrenal myelolipoma should exhibit symptoms more
clearly, and our data revealed that the size of the adrenal
myelolipoma is correlated with symptoms (Table 2). At
least in our cases, surgery does relieve symptoms. Although
there are no data regarding the relief of symptoms after
surgery, we do believe surgery can be useful in symptom-
atic patients.
Recently, clinical diagnosis has usually been based on the
abdominal CT because it is fast, is readily available, and
provides spatial resolution as well as differentiates tissues
by different CT Hounsfield units (HU). The typical CT find-
ings of these cases were well-defined lesions of heteroge-
neous and low-density tissue. Differential diagnoses include
retroperitoneal lipoma, retroperitoneal liposarcoma, retro-
peritoneal leiomyosarcoma, extra-renal angiomyolipoma,
and primary or metastatic adrenal malignancy. In both our
series and some other studies, it was sometimes initially
impressed to be malignant disease such as liposarcomaTable 2 Demographic and clinical data of the patient.
Size (cm) Male
Symptom No symptom
Left (n) Right (n) Left (n) Right (n)
0e6 2 4 11 12
6e10 1 9 2 6
10e20 2 7 2 5
20e30 0 3 1 2
30e40 0 2 1 0
40e50 1 0 0 0
Note: total, 112 cases; bilateral, 15 cases; and unknown, 19 cases.and leiomyosarcoma. Accurate preoperative diagnosis of
adrenal myelolipoma may be difficult because there are no
specific imaging criteria to diagnose it. Malignancy could not
be ruled out in half of our patients. Definitive diagnosis of
adrenal myelolipoma depends on cytological or histological
evaluation [8].
Fine needle aspiration or biopsy is the ultimate method
for diagnosis. However, unwanted fine needle biopsy may
result in complications with adrenal tumors. Adrenal mye-
lolipoma has a classic appearance, and some believe that
this might be sufficient for diagnosis. Therefore, careful
judgment should be made according to the patient’s
general condition and preferences. Management of adrenal
myelolipoma is usually conservative because the tumors are
generally asymptomatic and rarely show spontaneous
bleeding if the tumor is small. Once adrenal myelolipoma
is diagnosed, regular follow-up with sonography or CT is
recommended and surgery is reserved for symptomatic
cases. Some studies suggest surgical intervention for
symptomatic tumors, growing tumors, or tumors larger
than 10 cm to reduce the risk of developing abdominal pain
or life-threatening hemorrhage [8]. From the reviewed
papers, 12 of 70 (17.1%) cases whose tumor size was
greater than 6 cm experienced spontaneous rupture.
Therefore, elective surgery can prevent more severe
symptom presentation and life-threatening progression,Female Symptom
(%)Symptom No symptom
Left (n) Right (n) Left (n) Right (n)
1 5 3 11 24.4
5 2 3 6 50
3 6 4 3 56.3
0 2 0 0 62.5
0 0 0 0 66.7
0 0 0 0 100
Adrenal myelolipoma 381and can allow accurate diagnosis in patients with tumors
larger than 6 cm.
Castillo et al. [5] advocated laparoscopic adrenalec-
tomies for myelolipoma. They also mentioned that tumor
size did not preclude the indication for laparoscopic
approach even if the size was greater than 5 cm (the largest
one was 14 cm). We agree with this concept, and two of our
cases received laparoscopic adrenalectomy. In our series,
the largest size was 7.5 cm for laparoscopic intervention
and it also had a similar result.
Conclusion
Traditionally, this benign tumor will be treated conser-
vatively. It is unclear as to the indication of operation for
patients with the radiologic features of these tumors to
distinguish these tumors reliably from their malignant
counterparts. In the current study, we hope to offer
preliminary evidence concerning the benefit of surgery.
Surgery may be reserved for symptomatic cases and those
lesions that cannot be distinguished reliably. Elective
surgery is also recommended for prevention of sponta-
neous rupture in the group whose tumor size was greater
than 6 cm. Furthermore, minimally invasive laparoscopic
surgery may not only offer an alternative choice of
treatment, but encourage patients to receive an opera-
tion as well. Surgery still has its role in the management
of adrenal myelolipoma, although it is a benign tumor.
Further research is needed to establish an accurate treat-
ment protocol.References
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